Independent of its m5C methyltransferase activity, NSUN2 interacts with CUL4B to co‐regulate the EGFR/HER2 pathway, thereby mediating the sensitivity of CRC to lapatinib (Figure 8). Here, ERBB2 is linked to colorectal carcinoma.